期刊
BMC BIOLOGY
卷 17, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12915-019-0715-8
关键词
Intestinal microbiota; Microbiome; Microbiota transfer; Cholesterol metabolism; Enterohepatic cycle; Antibiotics; Dyslipidemia
类别
资金
- INSERM
- Fondation de France [00029519]
- French National Research Agency `Investissements d'avenir' [ANR-10-IAHU-05]
- foundation Lefoulon-Delalande/Institut de France
- Region Ile-de-France CORDDIM
- Crohn's & Colitis Foundation of America [370295] Funding Source: researchfish
Background Management of blood cholesterol is a major focus of efforts to prevent cardiovascular diseases. The objective of this study was to investigate how the gut microbiota affects host cholesterol homeostasis at the organism scale. Results We depleted the intestinal microbiota of hypercholesterolemic female Apoe(-/-) mice using broad-spectrum antibiotics. Measurement of plasma cholesterol levels as well as cholesterol synthesis and fluxes by complementary approaches showed that the intestinal microbiota strongly regulates plasma cholesterol level, hepatic cholesterol synthesis, and enterohepatic circulation. Moreover, transplant of the microbiota from humans harboring elevated plasma cholesterol levels to recipient mice induced a phenotype of high plasma cholesterol levels in association with a low hepatic cholesterol synthesis and high intestinal absorption pattern. Recipient mice phenotypes correlated with several specific bacterial phylotypes affiliated to Betaproteobacteria, Alistipes, Bacteroides, and Barnesiella taxa. Conclusions These results indicate that the intestinal microbiota determines the circulating cholesterol level and may thus represent a novel therapeutic target in the management of dyslipidemia and cardiovascular diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据